Sildenafil does not Improve Exercise Capacity under Acute Hypoxia Exposure.

Area of Science:

• Physiology
• Pharmacology
• Sports Science

Background:

• Hypoxic pulmonary vasoconstriction (HPV) increases pulmonary arterial pressure (PAP), potentially limiting physical performance during hypoxia.
• Sildenafil's known effect on reducing PAP suggests a potential role as an ergogenic aid or even a doping substance.

Purpose of the Study:

• To investigate the effects of sildenafil on cardiovascular, respiratory, and metabolic parameters.
• To assess sildenafil's impact on physical performance in normoxia and hypobaric hypoxia at rest and during exercise.

Main Methods:

• Double-blind, placebo-controlled crossover study involving 11 healthy volunteers.
• Administration of 100 mg sildenafil or placebo one hour before testing.
• Testing included rest, maximal, and submaximal (60% VO2 max) exercise in normoxic and hypobaric hypoxic (4,000m) conditions.

Main Results:

• Sildenafil did not affect physical performance in normoxic conditions.
• No significant differences in cardiovascular or respiratory parameters were observed in hypoxic conditions at rest or during exercise.
• The data does not support the use of sildenafil for enhancing physical performance in non-acclimatized individuals.

Conclusions:

• Sildenafil does not appear to be an ergogenic aid for physical performance in healthy, non-acclimatized individuals exposed to acute hypobaric hypoxia.
• Further research may be needed to explore potential effects in different populations or under varying hypoxic conditions.